An AllTrials project

NCT05588648: An ongoing trial by MedPacto, Inc.

This trial is ongoing. It must report results 2 years, 1 month from now.

Full data

Full entry on ClinicalTrials.gov NCT05588648
Title A Phase I/II, Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of Vactosertib as a Single Agent in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date May 1, 2023
Completion date Dec. 31, 2027
Required reporting date Dec. 30, 2028, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Nov. 17, 2026
Days late None